News

Press Release

August 27, 2025

CancerLinQ Receives ASCO Certified RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources

Press Release

August 18, 2025

ConcertAI Appoints Michael Myshrall as Chief Financial Officer

Press Release

May 1, 2025

ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth

Press Release

April 22, 2025

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

Press Release

April 21, 2025

EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year® 2025 New England Award finalist

Press Release

March 26, 2025

Media Feature | ConcertAI & NeoGenomics Announce AI SaaS for Hematology Clinical Research

Artificial Intelligence

March 24, 2025

Media Feature | Inside NVIDIA and ConcertAI’s alliance to build AI agents for oncology trials

Press Release

March 18, 2025

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025

Advanced Visualization

February 25, 2025

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and ConcertAI’s TeraRecon Announce Strategic Collaboration Around Integrated AI and Advanced Visualization

SCOPE 2025

February 3, 2025

At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors

THE LATEST IN PRESS & MEDIA COVERAGE

Press Release

CancerLinQ Receives ASCO Certified RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources

Press Release

ConcertAI Appoints Michael Myshrall as Chief Financial Officer

Press Release

ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth

Press Release

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

Press Release

EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year® 2025 New England Award finalist

Press Release

Media Feature | ConcertAI & NeoGenomics Announce AI SaaS for Hematology Clinical Research

Artificial Intelligence

Media Feature | Inside NVIDIA and ConcertAI’s alliance to build AI agents for oncology trials

Press Release

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025

Advanced Visualization

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and ConcertAI’s TeraRecon Announce Strategic Collaboration Around Integrated AI and Advanced Visualization

SCOPE 2025

At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors